MYRIAD GENETICS, INC. Other Comprehensive Income (Loss), Net of Tax
MYRIAD GENETICS, INC. (MYGN) reported Other Comprehensive Income (Loss), Net of Tax of $4.00 million for the 12-month period ending 2017-06-30, per its 10-K filed 2017-08-09.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2017-08-09
- MYRIAD GENETICS, INC. other comprehensive income (loss), net of tax for fiscal 2017 was $4.00M.
- MYRIAD GENETICS, INC. other comprehensive income (loss), net of tax for fiscal 2016 was -$2.50M.
- MYRIAD GENETICS, INC. other comprehensive income (loss), net of tax for fiscal 2015 was -$5.50M.
- MYRIAD GENETICS, INC. other comprehensive income (loss), net of tax for fiscal 2014 was -$1.10M.
| Period end | Other Comprehensive Income (Loss), Net of Tax 12 month | Other Comprehensive Income (Loss), Net of Tax 12 month as first filed |
|---|---|---|
| 2017-06-30 | $4.00M 10-K · filed 2017-08-09 | |
| 2016-06-30 | -$2.50M 10-K · filed 2017-08-09 | |
| 2015-06-30 | -$5.50M 10-K · filed 2017-08-09 | |
| 2014-06-30 | -$1.10M 10-K · filed 2016-08-10 | -$1.09M 10-K · filed 2014-08-13 |
| 2013-06-30 | -$300.00K 10-K · filed 2015-08-12 | -$262.00K 10-K · filed 2013-08-14 |
| 2012-06-30 | -$313.00K 10-K · filed 2014-08-13 | |
| 2011-06-30 | $12.00K 10-K · filed 2013-08-14 | |
| 2010-06-30 | -$2.63M 10-K · filed 2012-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |